Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3332328 | HIV & AIDS Review | 2015 | 5 Pages |
Abstract
Saquinavir/r containing regimen remains a valuable and safe option for patients with indications to protease inhibitor based antiretroviral treatment.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
J. Kubicka, A. Ignatowska, J.D. Kowalska, I. Cielniak, P. Pulik, E. Bakowska, A. Chylak, E. Burkacka Firlag, A. Horban,